<?xml version="1.0" encoding="UTF-8"?>
<p>Lung cancer is the most common neoplasm that occurs among men and women in most countries. The GLOBOCAN 2012 estimated a total of 1,242,000 new cases in men and 583,000 in women. Lung cancer is histologically classified into two classes. These classes include small-cell and non-small-cell lung cancers (NSCLC). In the United States, it was approximated that 200,000 persons were diagnosed with lung cancer in 2010 and 160,000 deaths were reported. It is the main cause of mortality in both men and women. Approximately 27% of cancer deaths, which was reported in the USA during 2015 and 20% deaths reported from European Union in 2016 were due to lung cancer [
 <xref rid="B74-molecules-25-04435" ref-type="bibr">74</xref>]. Tobacco usage is the well-known risk factor that accounts for 80% to 90% of lung cancer development [
 <xref rid="B75-molecules-25-04435" ref-type="bibr">75</xref>]. There are various risk factors that are associated with the development of lung cancer. The major risk factors include age and cigarette smoking. Cigarette smoking increased dramatically in the United States of America and the European countries [
 <xref rid="B76-molecules-25-04435" ref-type="bibr">76</xref>].
</p>
